SERMO adds feature to Drug Ratings platform: 5 insights

Practice Management

SERMO, a global physician social network, unveiled an addition to its Drug Ratings platform.

Here are five insights:

 

1. The new feature allows physicians to research prescription drugs by FDA-approved indications.

 

2. SERMO Drug Ratings already enabled physicians to share their prescription drugs' reviews and ratings with each other.

 

3. Physicians rate the drugs based on efficacy, safety, tolerability, accessibility and adherence.

 

4. The addition allows physicians to compare different classes of drugs for specific conditions.

 

5. SERMO Drug Ratings includes 350,000 ratings and 23,000 comments. The tool encompasses more than 3,000 rated drugs.

 

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers